Krsnaa Diagnostics

Krsnaa Diagnostics FCF per Share

The Free Cash Flow per Share of Krsnaa Diagnostics (KRSNAA.NS) as of Oct 31, 2026 is -28.70 INR. In the previous year, Free Cash Flow per Share was -12.01 INR — a change of 138.95% (lower).

FCF per Share

-28.70INR

YoY

138.95%

Last updated:

Free Cash Flow per Share of Krsnaa Diagnostics is 2026 -28.70 INR. Free Cash Flow per Share of Krsnaa Diagnostics was 2025 -12.01 INR. It decreases by 138.95% lower compared to the previous year.

The Krsnaa Diagnostics FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
-12.64 INR
Jan 1, 2020
-37.71 INR
Jan 1, 2021
12.33 INR
Jan 1, 2022
-1.18 INR
Jan 1, 2023
-19.56 INR
Jan 1, 2024
-51.35 INR
Jan 1, 2025
-12.01 INR
Jan 1, 2026
-28.70 INR
The Krsnaa Diagnostics FCF per Share history
YEARFCF per ShareYoY
-28.70INR+138.95%
-12.01INR-76.61%
-51.35INR+162.55%
-19.56INR+1,557.81%
-1.18INR-109.56%
12.33INR-132.71%
-37.71INR+198.32%
-12.64INR-28.26%
-17.62INR-742.18%
2.74INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

Free Cash Flow per Share of Krsnaa Diagnostics is -28.70 INR in 2026.

Free Cash Flow per Share of Krsnaa Diagnostics changed from -12.01 INR to -28.70 INR, representing a 138.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Krsnaa Diagnostics

All Key Metrics — Krsnaa Diagnostics